Baseline requirements for novel agents being considered for phase II/III brain cancer efficacy trials: conclusions from the Adult Brain Tumor Consortium’s first workshop on CNS drug delivery
Stuart A. Grossman, Carlos G. Romo, Michelle A. Rudek, Jeffrey G. Supko, Joy Fisher, Burt Nabors, Patrick Y. Wen, David M. Peereboom, Benjamin M. Ellingson, William F. Elmquist, Fred G. Barker, David Kamson, Jann N. Sarkaria, William C. Timmer, Ranjit S. Bindra, Xiaobu Ye
Abstract
Author(s): Grossman, Stuart A; Romo, Carlos G; Rudek, Michelle A; Supko, Jeffrey; Fisher, Joy; Nabors, L Burt; Wen, Patrick Y; Peereboom, David M; Ellingson, Benjamin M; Elmquist, William; Barker, Fred G; Kamson, David; Sarkaria, Jann N; Timmer, William; Bindra, Ranjit S; Ye, Xiaobu
Topics & Concepts
GrossmanBrain cancerPsychoanalysisPsychologyMedicineCancerInternal medicineKeynesian economicsEconomicsGlioma Diagnosis and TreatmentRadiomics and Machine Learning in Medical ImagingBrain Metastases and Treatment